Replies

Probable Cause	Score (1-10)	Evidence Summary
De novo genetic mutations	10	Strong evidence from large-scale studies showing rare mutations in hundreds of genes (e.g., CHD8, SHANK3) directly contributing to ASD risk, often explaining severe cases.
Inherited genetic variants (polygenic risk)	10	Twin studies and GWAS indicate 40-80% heritability, with common variants across many genes cumulatively increasing risk.
Genetic syndromes (e.g., Fragile X, Rett)	9	Specific syndromes like Fragile X or Rett account for 5-10% of ASD cases, with clear genetic links.
Maternal valproate use during pregnancy	9	Strong association from studies showing 7.5% ASD rate in exposed children vs. 1.9% in controls; animal models support neurodevelopmental impact.
Advanced paternal age	8	Every 10-year increase raises risk by 21%; linked to de novo mutations in sperm.
Advanced maternal age	8	Every 10-year increase raises risk by 18%; associated with complications and mutations.
Maternal fever in second trimester	8	40% increased risk; linked to inflammation delaying fetal brain vessel formation.
Maternal infection during pregnancy (e.g., rubella, influenza)	7	Strong for rubella (high prevalence in exposed); mixed for others, but maternal immune activation in animal models supports.
Birth complications (e.g., hypoxia, ischemia)	7	Strong links with trauma/hypoxia; medium-large effects in meta-analyses.
Prenatal air pollution exposure	7	Early-life exposure (e.g., PM2.5) linked to risk; induces DNA damage.
Prenatal pesticide exposure (e.g., chlorpyrifos)	7	Associated with ASD; induces DNA breaks in susceptibility genes.
Maternal autoantibodies to fetal brain	6	May account for 12-22% of cases; circumstantial evidence from maternal studies.
Heavy metal exposure (e.g., lead, mercury)	6	Linked via oxidative DNA damage; occupational/residential evidence.
Phthalate exposure	6	Downregulates repair genes; associated with ASD risk.
Brominated flame retardants	6	Neurotoxic effects on developing brain; linked to hormone disruption.
Maternal obesity	5	36% increased risk in meta-analyses; weak but significant.
Gestational diabetes	5	43% increased risk; weak association in cohorts.
Maternal SSRI use during pregnancy	3	50% increased risk, but likely confounded by maternal depression.
Vaccines (e.g., MMR)	1	Debunked by extensive research; no causal link, though controversial in suppressed claims.
Thimerosal in vaccines	1	No association in studies; retracted claims and suppressed theories lack evidence.

Autism Probable Cause Score (1-10) Evidence Summary
De novo genetic mutations 10 Strong evidence from large-scale studies showing rare mutations in hundreds of genes (e.g., CHD8, SHANK3) directly contributing to ASD risk, often explaining severe cases.
Inherited genetic variants (polygenic risk) 10 Twin studies and GWAS indicate 40-80% heritability, with common variants across many genes cumulatively increasing risk.
Genetic syndromes (e.g., Fragile X, Rett) 9 Specific syndromes like Fragile X or Rett account for 5-10% of ASD cases, with clear genetic links.
Maternal valproate use during pregnancy 9 Strong association from studies showing 7.5% ASD rate in exposed children vs. 1.9% in controls; animal models support neurodevelopmental impact.
Advanced paternal age 8 Every 10-year increase raises risk by 21%; linked to de novo mutations in sperm.
Advanced maternal age 8 Every 10-year increase raises risk by 18%; associated with complications and mutations.
Maternal fever in second trimester 8 40% increased risk; linked to inflammation delaying fetal brain vessel formation.
Maternal infection during pregnancy (e.g., rubella, influenza) 7 Strong for rubella (high prevalence in exposed); mixed for others, but maternal immune activation in animal models supports.
Birth complications (e.g., hypoxia, ischemia) 7 Strong links with trauma/hypoxia; medium-large effects in meta-analyses.
Prenatal air pollution exposure 7 Early-life exposure (e.g., PM2.5) linked to risk; induces DNA damage.
Prenatal pesticide exposure (e.g., chlorpyrifos) 7 Associated with ASD; induces DNA breaks in susceptibility genes.
Maternal autoantibodies to fetal brain 6 May account for 12-22% of cases; circumstantial evidence from maternal studies.
Heavy metal exposure (e.g., lead, mercury) 6 Linked via oxidative DNA damage; occupational/residential evidence.
Phthalate exposure 6 Downregulates repair genes; associated with ASD risk.
Brominated flame retardants 6 Neurotoxic effects on developing brain; linked to hormone disruption.
Maternal obesity 5 36% increased risk in meta-analyses; weak but significant.
Gestational diabetes 5 43% increased risk; weak association in cohorts.
Maternal SSRI use during pregnancy 3 50% increased risk, but likely confounded by maternal depression.
Vaccines (e.g., MMR) 1 Debunked by extensive research; no causal link, though controversial in suppressed claims.
Thimerosal in vaccines 1 No association in studies; retracted claims and suppressed theories lack evidence.